UNBSF
Uni-Bio Science Group Limited, an investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People's Republic of China. It operates through Chemical Pharmaceutical Products, Biological Pharmaceutical Products, and Pipeline Products segments. The company provides BOGUTAI, a disposable injection pen fo… Read more
UNBSF (UNBSF) - Total Liabilities
Latest total liabilities as of June 2025: $173.20 Million USD
Based on the latest financial reports, UNBSF (UNBSF) has total liabilities worth $173.20 Million USD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
UNBSF - Total Liabilities Trend (2020–2024)
This chart illustrates how UNBSF's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
UNBSF Competitors by Total Liabilities
The table below lists competitors of UNBSF ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Mikobeaute International Co., Ltd.
TWO:6574
|
Taiwan | NT$257.70 Million |
|
Garuda Indonesia Persero Tbk
JK:GIAA
|
Indonesia | Rp138.13 Trillion |
|
Sun Summit Minerals Corp
OTCQB:SMREF
|
USA | $3.15 Million |
|
Mongolia Growth Group Ltd.
PINK:MNGGF
|
USA | $3.54 Million |
|
Landis Taipei Hotel Co Ltd
TWO:5703
|
Taiwan | NT$448.88 Million |
|
ALBIS Leasing AG
XETRA:ALG
|
Germany | €196.41 Million |
|
Bergen Carbon Solutions A/S
OL:BCS
|
Norway | Nkr17.54 Million |
Liability Composition Analysis (2020–2024)
This chart breaks down UNBSF's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.40 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.45 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.31 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how UNBSF's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for UNBSF (2020–2024)
The table below shows the annual total liabilities of UNBSF from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $191.91 Million | +25.58% |
| 2023-12-31 | $152.82 Million | +56.38% |
| 2022-12-31 | $97.72 Million | +4.76% |
| 2021-12-31 | $93.29 Million | +47.36% |
| 2020-12-31 | $63.31 Million | -- |